Results 301 to 310 of about 337,127 (342)

Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.

Annals of Surgery, 2020
OBJECTIVE To determine whether prognostic nutritional index (PNI) affects clinical outcome through local immunity in esophageal cancers. BACKGROUND PNI is an indicator of nutritional status and systemic immune competence, and has attracted attention as
K. Okadome, Y. Baba, T. Yagi, Y. Kiyozumi, T. Ishimoto, M. Iwatsuki, Y. Miyamoto, N. Yoshida, Masayuki Watanabe, H. Baba   +9 more
semanticscholar   +1 more source

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Journal of the American Medical Association (JAMA)
Importance The association of tumor-infiltrating lymphocyte (TIL) abundance in breast cancer tissue with cancer recurrence and death in patients with early-stage triple-negative breast cancer (TNBC) who are not treated with adjuvant or neoadjuvant ...
R. Leon-Ferre, S. Jonas, R. Salgado, S. Loi, V. D. de Jong, Jodi M. Carter, T. Nielsen, S. Leung, N. Riaz, Stephen K. L. Chia, G. Jules-Clement, G. Curigliano, C. Criscitiello, V. Cockenpot, M. Lambertini, Vera J. Suman, B. Linderholm, John W M Martens, C. V. van Deurzen, A. M. Timmermans, T. Shimoi, S. Yazaki, M. Yoshida, Sung-Bae Kim, H. Lee, M. Dieci, Guillaume Bataillon, A. Vincent‐Salomon, Fabrice André, M. Kok, Sabine C. Linn, M. Goetz, S. Michiels   +32 more
semanticscholar   +1 more source

Tumor‐infiltrating lymphocytes in breast FNA biopsy cytology: A predictor of tumor‐infiltrating lymphocytes in histologic evaluation

Cancer Cytopathology, 2022
BackgroundTumor‐infiltrating lymphocytes (TILs) are associated with various clinicopathological features. Using cytologic specimens for assessing TILs remains to be established. This retrospective study aimed to establish a practical method to assess TILs in cytologic samples.MethodsThe authors found 1101 breast fine‐needle aspiration biopsy (FNAB ...
Toru Odate, Minh‐Khang Le, Masataka Kawai, Mizuki Kubota, Yohei Yamaguchi, Tetsuo Kondo   +5 more
openaire   +2 more sources

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy and Neoantigens

The Cancer Journal, 2017
The adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes has been shown to be effective at mediating tumor regression in more than half of patients with metastatic melanoma and in mediating long-term complete regression in approximately one fourth of all patients with this cancer.
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy

The Cancer Journal, 2015
Autologous adoptive T-cell therapies have made tremendous strides over the last few years with excitement currently being generated by technologies that can reprogram T-cell specificities toward any desired antigen including chimeric antigen receptors and recombinant T-cell receptors.
openaire   +2 more sources

Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis

Immunologic research, 2023
Hina Qayoom, Shazia Sofi, M. A. Mir
semanticscholar   +1 more source

Reporting Tumor Infiltrating Lymphocytes

2012
The presence of many tumor infiltrating lymphocytes (TILs) in primary cutaneous melanoma is associated with a better prognosis. The degree of lymphocytic interaction with the tumor cells is graded as “brisk”, “non-brisk” or “absent” as defined below:
Kasia Szyfelbein Masterpol, Andrea Primiani, Lyn McDivitt Duncan   +2 more
openaire   +1 more source

Predictors of Tumor-Infiltrating Lymphocyte Efficacy in Melanoma

Immunotherapy, 2015
In the past decades, the increasing knowledge in cellular immunology and tumor-host immune interactions, led to the development of immunotherapy approaches. Immunotherapy, based on adoptive cell transfer of ex vivo activated and expanded tumor-infiltrating T lymphocytes (TILs), has shown promising clinical results in patients with metastatic melanoma ...
Dragoslav, Zikich, Jacob, Schachter, Michal J, Besser   +2 more
openaire   +2 more sources

TUMOR INFILTRATING LYMPHOCYTES*

Annals of the New York Academy of Sciences, 1976
E, Klein, S, Becker, E, Svedmyr, M, Jondal, F, Vánky   +4 more
openaire   +2 more sources